BDX
$168.74
Becton Dickinson
$1.60
.96%
BDX
Earnings Whisper ®
N/A
3rd Quarter June 2025
Consensus: $3.46
Revenue: N/A
Share
Watch
Guidance announcement made Thursday, May 1, 2025
Latest EPS
Thursday, May 1, 2025
What do you expect when BDX reports earnings?
Where is BDX's stock price going from here?
Analysts
Pivots
Resistance
$172.28
$169.99
$168.56
Support
$164.84
$162.55
$161.12
Description
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.